Clearmind Medicine
(NASDAQ) CMND
Clearmind Medicine Financials at a Glance
Market Cap
$2.44M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.71M
EPS (TTM)
$-24.14
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$1.15
Volume
413
Open
$1.15
Price
$1.15
Volume
413
Open
$1.15
Previous Close
$1.15
Daily Range
$1.15 - $1.15
52-Week Range
$0.59 - $52.40
Dividend
$0.00
Beta (Volatility)
0.45 (Low)
Price
$1.15
Volume
413
Open
$1.15
Previous Close
$1.15
Daily Range
$1.15 - $1.15
52-Week Range
$0.59 - $52.40
CMND News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clearmind Medicine
Industry
Pharmaceuticals
Sector
Health CareCEO
Adi Zuloff-Shani, PhD
Website
www.clearmindmedicine.comHeadquarters
Vancouver, BC V6H 1A5, CA
CMND Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-120%
Return on Capital
-1%
Return on Assets
-69%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.44M
Shares Outstanding
2.09M
Volume
413
Short Interest
0.00%
Avg. Volume
250.26K
Financials (TTM)
Gross Profit
$49.36K
Operating Income
$5.67M
EBITDA
$3.72M
Operating Cash Flow
$4.73M
Capital Expenditure
$0.00
Free Cash Flow
$4.73M
Cash & ST Invst.
$5.58M
Total Debt
$1.78M
Clearmind Medicine Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$13.32K
+24.9%
Gross Margin
0.00%
N/A
Market Cap
$2.44M
N/A
Market Cap/Employee
$610.98K
N/A
Employees
4
N/A
Net Income
$3.85M
-143.9%
EBITDA
$3.64M
-144.5%
Quarterly Fundamentals
Net Cash
$10.33M
+19.4%
Accounts Receivable
$437.38K
+41.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$7.97K
-86.2%
Return on Assets
-69.22%
N/A
Return on Invested Capital
-1.15%
N/A
Free Cash Flow
$2.08M
-11.7%
Operating Cash Flow
$2.08M
-11.7%